Kevin R. Vasquez | Lead Operating Director | Member, ESG Governance Committee
Kevin R. Vasquez has more than 40 years’ experience in the animal-health industry and is the former chairman, president and CEO of Henry Schein Animal Health. Mr. Vasquez has held several senior executive positions during his career including chairman, president and CEO of Butler Schein Animal Health; president & COO of Butler Animal Health; executive vice president of Fermenta Animal Health; and vice president of the Cattle & Companion Animal Business Unit at Boehringer Ingelheim Vetmedica, Inc. He has served the industry as a member of the board of directors of the National Cattlemen’s Association, the American Feed Industry Association, the American Veterinary Distributors Association, Animalytics, Fermenta Animal Health, and Velcera Pharmaceuticals, Inc. He is also past chairman of the AFIA National Animal Health Committee.
In addition to serving as lead operating director of the board of Wedgewood Pharmacy, Mr. Vasquez currently serves on the boards of directors of both Mission Veterinary Partners, which currently owns more than 250 companion-animal hospitals, and Piedmont Pharmaceuticals, an FDA product-development company.
He is the recipient of several awards and distinctions including the Ernst & Young Entrepreneur of the Year Award for Ohio and Kentucky; The Western Carolina University Professional Achievement Award; the Ohio Association of Corporate Growth Award; The HSAH Outstanding Executive Award; and the HSAH Lifetime Achievement Award. He also was inducted as an honorary member of Beta Gamma Sigma, the international collegiate honor society recognizing the best in business.
Mr. Vasquez holds a BSBA degree from Western Carolina University as well as an MBA degree from Central Michigan University.
|
|
Marcy A. Bliss | Chief Executive Officer | Wedgewood Pharmacy
Marcy A. Bliss, chief executive officer of private-equity-owned Wedgewood Pharmacy, is responsible for overall company performance. She is a member of the board of directors and works with the owners, board, and management team to set and to ensure the delivery of patient care, prescriber service, corporate vision, mission, strategy, structure, and long-term goals. The company’s brand is recognized by 99% of veterinarians in the United States.
Under her leadership, in July 2018 the company acquired a significant competitor, Diamondback Drugs, in Scottsdale, Arizona, adding a second compounding pharmacy location and 180 employees. In 2020, the company acquired Wildlife Pharmaceuticals and its ZooPharm subsidiary; and opened a 503B Outsourcing Facility, Wedgewood Connect, in San Jose, California.
Most recently she was executive vice president of business operations and Marketing for Wedgewood Pharmacy, having begun her career with the company in early 1999 as employee number eight. Over the years, she assumed positions of increasing responsibility, many with a significant emphasis on marketing, product development, and pharmacy growth.
Prior to joining Wedgewood Pharmacy, she was chief marketing officer for the accounting and consulting firm, The Siegfried Group. Previously, she was a member of the staff of American Red Cross's (ARC) national office in Washington, DC, for planning, evaluation, and chapter operations and later served as communication manager for the Wilmington chapter of the ARC.
In addition to her role on the board of Wedgewood Pharmacy since 2016, she serves on the board of the New Jersey Business and Industry Association; is a member of the board of trustees of The Appel Farm Arts & Music Center (chair 2018-2020), where she is committed to supporting its mission of transforming lives through the arts; and is a member of the board of Together Women's Health, a network of integrated women’s healthcare providers based in Detroit. Previously, she served on the board of directors of the Tobin Foundation for the
Visually Impaired.
She holds a BS degree in Business/Marketing and Management Studies from the University of Maryland. A life-long learner, she has continued her education at Wharton Executive Education, University of Pennsylvania, Aresty Institute of Executive Education; the Hasso Plattner Institute of Design at Stanford University (Stanford, CA); and as an Executive Mastery client of Gap International.
|
|
Ben Shaw | President | Blue Rabbit Division
Benjamin Shaw is a passionate entrepreneur and investor with a proven track record in healthcare and technology ventures.
Shaw is the Founder, CEO and Chairman of Blue Rabbit, a fast-growing provider of technology-enabled disease management services for small animal and equine veterinary practitioners. He is also General Partner at Borealis Ventures, a healthcare investment fund seeking to partner with exceptional entrepreneurs to build market defining companies. Shaw has also been a Partner at Black Point Group since 2002, a private investment partnership.
Shaw is a Co-Founder and former President and CEO of Covetrus, one of the largest animal health companies in the world with over $4 billion in revenues, 5,500 team members and 100,000 customers in 100 countries. Shaw was the Co-Founder, President and CEO of Vets First Choice, a leading provider of cloud-based prescription management software and pharmacy services for veterinary practitioners, prior to its sale to Covetrus for $1.9 billion in 2019.
Shaw has been honored as an EY Entrepreneur of the Year New England, Goldman Sachs 100 Most Intriguing Entrepreneurs, Maine Governor’s Award for Business Excellence and the NEVY Healthcare Exit of the Year. He has served as a Founding Director for Maine Huts & Trails and served on the Corporation of The Jackson Laboratory. He is also an active member of Young Presidents Organization and an alumni advisor to Bates College, where he graduated with a triple B.A. in biology, political science and environmental sciences.
|
|
Peter Berweger | Managing Director | Partners Group
Peter Berweger is part of the Private Equity Health and Life Europe Team of Partners Group, based in Zug, Switzerland, and he is a member of the Private Equity Health and Life Investment Committee. He is a member of the board of directors of the firm's portfolio company Wedgewood Pharmacy.
Peter joined Partners Group in 2021 and has 25 years of industry experience with a strong operating background. Prior to joining Partners Group, Peter was Managing Director at Paine Schwartz Partners, a US private equity firm where he led the operating team and also operated two portfolio companies as the CEO. Prior to that he held senior leadership positions at Syngenta and KPMG.
Peter is an economist and accountant by background and holds an MBA degree from London Business School and Columbia University, New York.
|
|
Sofia Gerard| Investment Leader, Private Equity Health and Life | Partners Group
Sofia Gerard is part of the Private Equity Health and Life Americas Team of Partners Group, based in New York. She is a member of the board of directors of the firm's portfolio companies PCI Pharma Services, Wedgewood Pharmacy, Blue River PetCare, and Axia Women's Health.
She has been with Partners Group since 2013. Prior to joining Partners Group, she worked at UBS, a Swiss multinational investment bank and financial services company founded and based in Switzerland.
She holds a bachelor’s degree in Economics from the Wharton School of the University of Pennsylvania.
|
|
DavidA. Kamenetzky | Board Member | Founder, K4 Investments
David A. Kamenetzky has broad executive experience in corporate strategy, reputation management, regulatory, legal, antitrust, and compliance matters across global consumer industries, as well as financial services. He has operated in the most important markets, reaching from the U.S. to the EU, China, India, Africa, and Latin America.
Mr. Kamenetzky has held several senior executive positions during his career including CEO of Joh. A. Benckiser; member and Group Executive Committee at Anheuser-Busch InBev; and member of the Leadership Team, Mars Incorporated, where he developed an intimate knowledge of the pet and veterinary-care market.
He has extensive board experience as a member of the board of Ku¨hne + Nagel International AG, former chairman of JAB Investors, and former board member of DKSH Holdings. He also has spent significant time in the non-for-profit sector as the founding chairman of the Alfred Landecker Foundation, one of the largest European philanthropic organizations dedicated to the memory of the Holocaust, and a former chairman of the European Union of Jewish Students. He is past finance chair of Washington Performing Arts.
He holds a graduate degree in Business Administration from the University of St. Gallen as well as an MS degree in Foreign Service from the Georgetown University School of Foreign Service. He is a Swiss and German citizen and U.S. Green Card holder.
|
|
Dennis Maloney | Board Member | Chief Innovation Officer and Senior Vice President (Retired) | Domino’s Pizza
Dennis Maloney served as Domino's Pizza’s senior vice president and chief innovation officer. He led Domino’s overall innovation strategy, overseeing the Digital Experience, Loyalty, and Operations Innovation teams. Mr. Maloney previously served as Domino's vice president and chief digital officer after joining Domino's as vice president of Multimedia Marketing.
During his 12-year tenure, he was instrumental in growing Domino's digital sales to more than 75% of total U.S. sales. He led the introduction of several innovative digital capabilities – including the development of the iPhone, Android, and iPad ordering applications, the launch of consumer profiles, Easy Order, loyalty, voice ordering capabilities, and the Hotspots delivery platform. He also championed the launch of several Domino’s proprietary “AnyWare” ordering platforms including those developed for Google Home, Facebook Messenger, Apple Watch, and Amazon Echo among several others. He has most recently been leading in-store and delivery innovation, including the GPS delivery-tracking program, Domino's Carside Delivery capabilities, and testing autonomous pizza delivery.
His previous experience includes more than 14 years in marketing and e-commerce at leading global companies including The Coca-Cola Co. and Procter & Gamble.
Maloney served in the U.S. Navy as a submarine officer on the USS Atlanta and as a systems engineering instructor at the U.S. Naval Academy in Annapolis, Maryland. He holds a BS degree in Mechanical Engineering from the U.S. Naval Academy, and an MS degree in Mechanical Engineering from The Catholic University of America. He also has graduate-level training in nuclear engineering from the Naval Nuclear Power School.
Return to top.
|